Claims for Patent: 8,637,054

Summary for Patent: 8,637,054

Title:	Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
Abstract:	This invention concerns an ophthalmic solution including:
Inventor(s):	Mercier Fabrice
Assignee:	Laboratoires Thea
Application Number:	US13595165
Patent Claims:	1. An ophthalmic solution consisting of:about 0.005% (w/v) of latanoprost;about 5% (w/v) of macrogol glycerol hydroxystearate 40;about 0.1% (w/v) of carbomer 974P;about 0.05% (w/v) of sodium EDTA;about 1% (w/v) of PEG 4000;about 3.5% (w/v) of sorbitol;sodium hydroxide; andwater; wherein the ophthalmic solution has a pH of about 7.0.2. The solution of claim 1 , wherein the solution has a Brookfield viscosity at 25° C. between 8 and 20 mPa·s.3. A method for treating open-angle glaucoma or reducing intraocular pressure comprising administration of a solution of to an individual in need thereof.4. The method of claim 1 , comprising topically administering one drop of the solution of a day to each eye in humans or animals.5. Single-use or multi-dose bottle made of LDPE containing no additives containing the ophthalmic solution covered by .